Need Help? Chat Now With a Live Representative!

ARG One of 16 Companies Selected to Participate in Virginia Trade Program

ARG One of 16 Companies Selected to Participate in Virginia Trade Program

ARG One of 16 Companies Selected to Participate in Virginia Trade Program

January 19, 2022

The Virginia Economic Development Partnership (VEDP) recently announced in a press release the “acceptance of 16 companies into its two-year Virginia Leaders in Export Trade (VALET) program.” Atlantic Research Group (ARG) is among the participants.

According to the release: “The VALET program assists companies in the Commonwealth that are committed to international exporting as a growth strategy. To participate, each business must meet both quantitative and qualitative selection criteria, and participating firms are chosen based on their dedication to growing export sales. To date, 393 Virginia companies have been accepted to participate in the VALET program.”

ARG, with offices in Charlottesville, Virginia (home), London, Amsterdam, Steinhausen, Warsaw, and Sydney, is an ideal company to take part in this initiative. 

CEO Paul Bishop said: “We have been deliberate yet active in growing our organization. In the past few years, we have made a strategic acquisition in Europe, and opened offices in locations around the world. We are always looking for opportunities to make our footprint larger, and the VALET program is our next step. We are grateful to the Commonwealth for the opportunity.”

Mike Baker, Senior Vice President of Business Development added: “The VALET program provides us a platform to further build our brand and allow growth with our clients. There is a cachet attached to being part of VALET, and our aim is to leverage the program to tell ARG’s story in the global marketplace. As a full service CRO, we have the capacity to help a lot of emerging companies get their drugs developed.” 

ARG, founded in 2004, is focused on oncology, immunology and neurology, with more than 50 market authorizations.

To read the entire release from the Virginia Economic Development Partnership, please click here.

ARG and ADMA Biologics Celebrate FDA Approval of Bivigam for Pediatric Population

ARG and ADMA Biologics Celebrate FDA Approval of Bivigam for Pediatric Population

Atlantic Research Group, a pioneer in the immunology space since 2004, proudly announces the FDA approval of Bivigam for pediatric […]

March 18, 2024
ARG Appoints Dr. Victoria Allgood Vice President, Scientific Affairs, Oncology

ARG Appoints Dr. Victoria Allgood Vice President, Scientific Affairs, Oncology

CHARLOTTESVILLE, Va., April 11, 2023 — Victoria Allgood, PhD, has joined Atlantic Research Group (ARG) as Vice President, Scientific Affairs, […]

April 11, 2023
Atlantic Research Group Appoints Jeffrey H. Lawson, MD, PhD Chief Medical Officer

Atlantic Research Group Appoints Jeffrey H. Lawson, MD, PhD Chief Medical Officer

CHARLOTTESVILLE, Va., March 1, 2023 — Jeffrey H. Lawson, MD, PhD has joined Atlantic Research Group (ARG) as Chief Medical […]

March 1, 2023
GO TO TOP